AQST
Price
$2.86
Change
+$0.01 (+0.35%)
Updated
Apr 25, 02:16 PM (EDT)
Capitalization
383.26M
11 days until earnings call
OGI
Price
$1.19
Change
+$0.03 (+2.59%)
Updated
Apr 25, 02:41 PM (EDT)
Capitalization
200.85M
Ad is loading...

AQST vs OGI

Header iconAQST vs OGI Comparison
Open Charts AQST vs OGIBanner chart's image
Aquestive Therapeutics
Price$2.86
Change+$0.01 (+0.35%)
Volume$1.33K
Capitalization383.26M
Organigram Global
Price$1.19
Change+$0.03 (+2.59%)
Volume$563
Capitalization200.85M
AQST vs OGI Comparison Chart
Loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AQST vs. OGI commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQST is a StrongBuy and OGI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AQST: $2.85 vs. OGI: $1.16)
Brand notoriety: AQST and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AQST: 40% vs. OGI: 63%
Market capitalization -- AQST: $383.26M vs. OGI: $200.85M
AQST [@Pharmaceuticals: Other] is valued at $383.26M. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AQST’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • AQST’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, AQST is a better buy in the long-term than OGI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AQST’s TA Score shows that 6 TA indicator(s) are bullish while OGI’s TA Score has 5 bullish TA indicator(s).

  • AQST’s TA Score: 6 bullish, 3 bearish.
  • OGI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AQST is a better buy in the short-term than OGI.

Price Growth

AQST (@Pharmaceuticals: Other) experienced а +13.55% price change this week, while OGI (@Pharmaceuticals: Other) price change was +8.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.49%. For the same industry, the average monthly price growth was -1.51%, and the average quarterly price growth was -9.89%.

Reported Earning Dates

AQST is expected to report earnings on Aug 12, 2025.

OGI is expected to report earnings on Nov 27, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+4.49% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AQST($383M) has a higher market cap than OGI($201M). AQST YTD gains are higher at: -19.944 vs. OGI (-27.950). AQST has higher annual earnings (EBITDA): 1.18M vs. OGI (-195.74M). OGI has more cash in the bank: 42.3M vs. AQST (23.9M). OGI has less debt than AQST: OGI (136K) vs AQST (33.3M). OGI has higher revenues than AQST: OGI (161M) vs AQST (50.6M).
AQSTOGIAQST / OGI
Capitalization383M201M191%
EBITDA1.18M-195.74M-1%
Gain YTD-19.944-27.95071%
P/E RatioN/AN/A-
Revenue50.6M161M31%
Total Cash23.9M42.3M57%
Total Debt33.3M136K24,485%
FUNDAMENTALS RATINGS
AQST vs OGI: Fundamental Ratings
AQST
OGI
OUTLOOK RATING
1..100
1921
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
8484
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AQST's Valuation (36) in the Pharmaceuticals Major industry is in the same range as OGI (53) in the null industry. This means that AQST’s stock grew similarly to OGI’s over the last 12 months.

AQST's Profit vs Risk Rating (90) in the Pharmaceuticals Major industry is in the same range as OGI (100) in the null industry. This means that AQST’s stock grew similarly to OGI’s over the last 12 months.

OGI's SMR Rating (92) in the null industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that OGI’s stock grew similarly to AQST’s over the last 12 months.

OGI's Price Growth Rating (84) in the null industry is in the same range as AQST (84) in the Pharmaceuticals Major industry. This means that OGI’s stock grew similarly to AQST’s over the last 12 months.

OGI's P/E Growth Rating (96) in the null industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that OGI’s stock grew similarly to AQST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AQSTOGI
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIDVX17.810.37
+2.12%
Calamos Dividend Growth I
MGINX10.33N/A
N/A
DWS Global Macro Inst
ACFOX58.83N/A
N/A
American Century Focused Dynamic Gr Inv
JATIX55.99N/A
N/A
Janus Henderson Glb Tech and Innovt I
RAZCX10.30N/A
N/A
Russell Inv Multi-Asset Strat C

AQST and

Correlation & Price change

A.I.dvisor tells us that AQST and EOLS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AQST and EOLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQST
1D Price
Change %
AQST100%
+1.06%
EOLS - AQST
31%
Poorly correlated
+2.85%
ETON - AQST
29%
Poorly correlated
+2.00%
SCYX - AQST
28%
Poorly correlated
+9.78%
OGI - AQST
28%
Poorly correlated
+7.41%
ASRT - AQST
26%
Poorly correlated
+4.20%
More

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
+7.41%
SNDL - OGI
67%
Closely correlated
+4.23%
CRON - OGI
63%
Loosely correlated
+3.35%
TLRY - OGI
62%
Loosely correlated
+11.81%
CGC - OGI
61%
Loosely correlated
+20.16%
ACB - OGI
52%
Loosely correlated
+7.05%
More